Clopidogrel-induced mixed hepatocellular and cholestatic liver injury

Howard J. Willens

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

An 81-year-old woman developed symptomatic liver disease 3 weeks after beginning clopidogrel as adjunctive antiplatelet therapy for a coronary stent implantation. Symptomatic liver disease associated with short-term periprocedural administration of clopidogrel for coronary stenting has not been well described. The clinical significance of this event as well as a possible interaction between clopidogrel and other drugs metabolized by the cytochrome P450 2C9 pathways coadministered to this patient are discussed.

Original languageEnglish
Pages (from-to)317-318
Number of pages2
JournalAmerican Journal of Therapeutics
Volume7
Issue number5
StatePublished - Dec 1 2000
Externally publishedYes

Fingerprint

clopidogrel
Liver Diseases
Liver
Wounds and Injuries
Cytochrome P-450 Enzyme System
Stents
Pharmaceutical Preparations

Keywords

  • Clopidogrel
  • Drug-induced hepatotoxicity

ASJC Scopus subject areas

  • Pharmacology

Cite this

Clopidogrel-induced mixed hepatocellular and cholestatic liver injury. / Willens, Howard J.

In: American Journal of Therapeutics, Vol. 7, No. 5, 01.12.2000, p. 317-318.

Research output: Contribution to journalArticle

@article{ed65f33d6eb843f68455da095eee171c,
title = "Clopidogrel-induced mixed hepatocellular and cholestatic liver injury",
abstract = "An 81-year-old woman developed symptomatic liver disease 3 weeks after beginning clopidogrel as adjunctive antiplatelet therapy for a coronary stent implantation. Symptomatic liver disease associated with short-term periprocedural administration of clopidogrel for coronary stenting has not been well described. The clinical significance of this event as well as a possible interaction between clopidogrel and other drugs metabolized by the cytochrome P450 2C9 pathways coadministered to this patient are discussed.",
keywords = "Clopidogrel, Drug-induced hepatotoxicity",
author = "Willens, {Howard J.}",
year = "2000",
month = "12",
day = "1",
language = "English",
volume = "7",
pages = "317--318",
journal = "American Journal of Therapeutics",
issn = "1075-2765",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Clopidogrel-induced mixed hepatocellular and cholestatic liver injury

AU - Willens, Howard J.

PY - 2000/12/1

Y1 - 2000/12/1

N2 - An 81-year-old woman developed symptomatic liver disease 3 weeks after beginning clopidogrel as adjunctive antiplatelet therapy for a coronary stent implantation. Symptomatic liver disease associated with short-term periprocedural administration of clopidogrel for coronary stenting has not been well described. The clinical significance of this event as well as a possible interaction between clopidogrel and other drugs metabolized by the cytochrome P450 2C9 pathways coadministered to this patient are discussed.

AB - An 81-year-old woman developed symptomatic liver disease 3 weeks after beginning clopidogrel as adjunctive antiplatelet therapy for a coronary stent implantation. Symptomatic liver disease associated with short-term periprocedural administration of clopidogrel for coronary stenting has not been well described. The clinical significance of this event as well as a possible interaction between clopidogrel and other drugs metabolized by the cytochrome P450 2C9 pathways coadministered to this patient are discussed.

KW - Clopidogrel

KW - Drug-induced hepatotoxicity

UR - http://www.scopus.com/inward/record.url?scp=0034278708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034278708&partnerID=8YFLogxK

M3 - Article

C2 - 11317178

AN - SCOPUS:0034278708

VL - 7

SP - 317

EP - 318

JO - American Journal of Therapeutics

JF - American Journal of Therapeutics

SN - 1075-2765

IS - 5

ER -